Routinely measured blood cell tests could be used to stratify IPF patients by risk for poor outcomes and lung transplantation allocation, Australian research suggests. Increased monocyte count is a predictor of survival in patients with idiopathic pulmonary fibrosis, an analysis of data from the Australian IPF registry has shown. Respiratory physicians have confirmed US results ...
Monocyte count a potential biomarker for IPF prognosis, Australian registry data show
By Michael Woodhead
13 Feb 2020